1. Home
  2. RNGR vs ANNX Comparison

RNGR vs ANNX Comparison

Compare RNGR & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNGR
  • ANNX
  • Stock Information
  • Founded
  • RNGR 2017
  • ANNX 2011
  • Country
  • RNGR United States
  • ANNX United States
  • Employees
  • RNGR N/A
  • ANNX N/A
  • Industry
  • RNGR Oilfield Services/Equipment
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNGR Energy
  • ANNX Health Care
  • Exchange
  • RNGR Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • RNGR 279.8M
  • ANNX 263.3M
  • IPO Year
  • RNGR 2017
  • ANNX 2020
  • Fundamental
  • Price
  • RNGR $12.34
  • ANNX $2.51
  • Analyst Decision
  • RNGR Hold
  • ANNX Strong Buy
  • Analyst Count
  • RNGR 1
  • ANNX 4
  • Target Price
  • RNGR $13.00
  • ANNX $12.50
  • AVG Volume (30 Days)
  • RNGR 205.5K
  • ANNX 1.9M
  • Earning Date
  • RNGR 07-28-2025
  • ANNX 08-11-2025
  • Dividend Yield
  • RNGR 1.93%
  • ANNX N/A
  • EPS Growth
  • RNGR 27.70
  • ANNX N/A
  • EPS
  • RNGR 0.87
  • ANNX N/A
  • Revenue
  • RNGR $569,400,000.00
  • ANNX N/A
  • Revenue This Year
  • RNGR $11.70
  • ANNX N/A
  • Revenue Next Year
  • RNGR N/A
  • ANNX N/A
  • P/E Ratio
  • RNGR $14.26
  • ANNX N/A
  • Revenue Growth
  • RNGR N/A
  • ANNX N/A
  • 52 Week Low
  • RNGR $10.56
  • ANNX $1.29
  • 52 Week High
  • RNGR $18.45
  • ANNX $7.85
  • Technical
  • Relative Strength Index (RSI)
  • RNGR 55.06
  • ANNX 51.40
  • Support Level
  • RNGR $11.44
  • ANNX $2.21
  • Resistance Level
  • RNGR $12.52
  • ANNX $2.68
  • Average True Range (ATR)
  • RNGR 0.40
  • ANNX 0.25
  • MACD
  • RNGR 0.04
  • ANNX -0.02
  • Stochastic Oscillator
  • RNGR 76.60
  • ANNX 59.19

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: